F
Financials.page
Company Fundamentals
Workspace
OverviewhomeCompaniesdirectoryAPI & MCPdevelopers
Company financial data, refreshed daily. Not investment advice.
Financials.page — company financial data, refreshed daily. Not investment advice. Legal & terms
Annual figures as reported in 10-K / 20-F / 40-F filings.
VSBC · CIK 0001697884

VITASPRING BIOMEDICAL CO., LTD.

Annual figures as reported, FY2017–FY2026. Ratios and growth rates derived on-page.

VSBC logo
Services-Commercial Physical & Biological Research
Company profile
HQ Riverside, CAIncorporated in NVFiscal year ends Jan 31Non-accelerated filer Smaller reporting company
Revenue
$0
Net income
−$415K
▲ +46.4% vs FY2025
Operating cash flow
−$3K
▲ +81.7% vs FY2025
Diluted EPS
$0.00

Revenue

Annual, as reported

02M4M’17’19’21’23’25’26$0

Net income

Losses shown in terracotta

−4M−2M0’17’19’21’23’25’26−$415K

Recent quarters

momentum · last 12 quarters
Revenue — Apr ’26 quarter
$0
Net income — Apr ’26 quarter
−$76K
▲ +5.8% vs Apr ’25
Revenue — trailing 12 months
$0
Diluted EPS — trailing 12 months
$0.00

Quarterly revenue

Discrete quarters; Q4 derived from the annual figure

00.30.50.81Jul ’23Jan ’24Jul ’24Jan ’25Jul ’25Jan ’26Apr ’26$0

Quarterly net income

Losses shown in terracotta

−300K−200K−100K0Jul ’23Jan ’24Jul ’24Jan ’25Jul ’25Jan ’26Apr ’26−$76K
QuarterRevenueRev. YoYGross marginNet incomeNet marginDiluted EPS
Apr ’26$0——−$76K—$0.00
Jan ’26$0——−$81K—$0.00
Oct ’25$0——−$143K—$0.00
Jul ’25$0——−$111K—$0.00
Apr ’25$0——−$81K—$0.00
Jan ’25$0——−$143K—$0.00
Oct ’24$0——−$196K—$0.00
Jul ’24$0——−$219K—$0.00

Profitability & returns

quality of earnings

Margins

Share of revenue kept at each line

-100%0%100%’18’19’20’21’22
Gross marginOperating marginNet margin

Returns on capital

Net income vs year-end equity and assets

-4000%-2000%0%’17’21’23’25
Return on equityReturn on assets

Cash flow

cash generation

Operating cash flow

Net cash from operations

−200K−100K0’17’19’21’23’25’26−$3K

Shareholder returns

capital allocation

Diluted shares outstanding

Falling count means buybacks outpace dilution

0100M200M’17’19’21’23’25’26207M

Balance sheet

financial position

Stockholders’ equity

At fiscal year end

−4M−2M0’17’19’22’24’26−$4.4M

Growth rates

compounding, annualized
Share count change (split-adjusted)
+127.3%
5y

Key ratios

derived per fiscal year
Fiscal yearGross marginOp. marginNet marginROEROACurrent ratio
FY2026————−2830.3%0.00×
FY2025————−5389.6%0.00×
FY2024————−814.4%0.01×
FY2023————−543.7%0.14×
FY202236.8%20.1%16.2%57.7%25.2%1.76×
FY202145.2%171.4%171.4%441.4%224.6%2.04×
FY202011.2%45.7%45.7%———
FY201979.8%−130.4%−130.4%——0.55×
FY201869.9%−39.3%−39.3%—−340.1%0.68×
FY2017———−1.5%—2.85×

Annual figures

as reported
Fiscal yearRevenueGross profitOp. incomeNet incomeDiluted EPSOp. cash flowCapexTotal assetsLiabilitiesEquityCashLT debt
FY2026$0$0−$385K−$415K$0.00−$3K—$15K$4.4M−$4.4M$2K—
FY2025$0$0−$680K−$775K$0.00−$15K—$14K$4.0M−$4.0M$0—
FY2024$0$0−$1.1M−$1.1M−$0.01−$35K—$137K$3.5M−$3.4M$0—
FY2023$0−$3.3M−$4.2M−$4.2M−$0.02−$78K—$766K$3.2M−$2.4M$30K—
FY2022$5.6M$2.1M$1.1M$910K$0.00−$270K—$3.6M$2.0M$1.6M$107K—
FY2021$248K$112K$425K$425K$0.00−$42K—$189K$93K$96K$45K—
FY2020$15K$2K$7K$7K$0.00−$105—$0$0—$0—
FY2019$17K$14K−$22K−$22K$0.00−$34K—$0$11K−$7K$105—
FY2018$16K$11K−$6K−$6K$0.00$401—$2K$13K−$3K$5K—
FY2017$0$0—−$45$0.00−$4K—$0$5K$3K$555—

Latest filings

the most recent regulatory filings
10-QQuarterly report2026-06-17 ↗10-KAnnual report2026-06-17 ↗10-QQuarterly report2026-06-17 ↗10-QQuarterly report2026-06-17 ↗10-QQuarterly report2026-06-15 ↗10-KAnnual report2026-06-08 ↗10-QQuarterly report2026-05-06 ↗10-QQuarterly report2026-04-22 ↗10-QQuarterly report2026-04-02 ↗10-KAnnual report2026-03-12 ↗

Company logos by Elbstream and unavatar.

All third-party trademarks, service marks, logos, and brand names used on this site are the property of their respective owners. The use of these logos is for identification and illustrative purposes only and does not imply any affiliation, sponsorship, or endorsement by the respective owners.